Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Other

iFabric Corp. Launches Frontline(TM) Clinically Validated Antimicrobial Scrubs at Major Canadian Wholesale Club Retailer

By The Northwire Desk — AI Analysis Feb 18, 2026 · 06:30 IFA · 1.93 IFABRIC CORP. J
IFA · Price

Executive Summary

  • iFabric Corp.’s subsidiary Intelligent Fabric Technologies (North America) Inc. (IFTNA) launched Frontline™, a new line of medical scrubs incorporating PROTX2® antimicrobial and ecoPEL™ durable‑water‑repellent technologies, now sold through a major Canadian wholesale club retailer (Costco).
  • The launch is backed by a peer‑reviewed clinical study published in the Journal of Hospital Infection that demonstrated statistically significant reductions in surface bacterial contamination on treated scrubs versus untreated controls.
  • iFabric highlights this as a “significant commercial milestone,” indicating scalability of its proprietary textile technologies and opening a pathway for broader market penetration in healthcare apparel.

Key Details

  • Launch Platform: Frontline™ scrubs are available online via Costco Canada (e‑commerce site).
  • Example product URLs:
    • https://www.costco.ca/frontline-womens-two-pocket-v-neck-scrub-top.product.4000369204.html
    • https://www.costco.ca/frontline-womens-scrub-jogger.product.4000425176.html
  • Technology Integration: Each garment combines:
  • PROTX2® – eco‑friendly antimicrobial and anti‑odor textile treatment.
  • ecoPEL™ – fluorine‑free durable water‑repellent (DWR) finish that maintains breathability.
  • Clinical Validation: Peer‑reviewed study (Journal of Hospital Infection, 2025) showed statistically significant bacterial reduction on scrubs treated with the PROTX2®/ecoPEL™ combination in real‑world healthcare settings. Full article: https://www.journalofhospitalinfection.com/article/S0195-6701(25)00222-1/fulltext
  • Commercial Significance:
  • Represents IFTNA’s second major retail adoption of its performance‑apparel technologies.
  • Positions IFTNA as an end‑to‑end partner from chemistry development through consumer‑ready product manufacturing at scale.
  • Anticipated future expansion to additional product assortments and potentially brick‑and‑mortar distribution, subject to retailer planning and member adoption.
  • Executive Commentary:
  • Giancarlo Beevis, President & CEO of IFTNA, emphasized the translation of peer‑reviewed clinical evidence into accessible apparel for healthcare professionals, noting the demand for antimicrobial solutions supported by rigorous data.
  • Forward‑Looking Statements: The release contains expectations regarding product adoption, market expansion, and performance attributes that are subject to risks and uncertainties.

Notable Quotes

“Frontline™ scrubs translate peer‑reviewed clinical evidence into accessible, everyday apparel built for the realities of modern healthcare – long shifts, frequent laundering, and regular exposure to bacteria from fluids and surfaces,” — Giancarlo Beevis, President & CEO, IFTNA.

“Healthcare professionals have increasingly demanded antimicrobial solutions supported by rigorous clinical data rather than marketing claims alone… positions IFTNA to address what we believe is a substantial and growing demand for clinically‑proven infection control apparel in healthcare settings.” — Giancarlo Beevis.

Read the original news release →

More from IFABRIC CORP. J

Jun 22, 2026 · 19:58

Early Warning Press Release - Hylton Karon Announces Disposition of Common Shares of iFabric Corp.

Other Jun 05, 2026 · 14:45

iFabric Closes $28M Bought Deal at a Discount as Revenue Surges 288% on Medical Scrubs and Footwear Boom

Financings Jun 02, 2026 · 16:29

iFabric Corp. Files Final Short Form Prospectus in Connection with Previously Announced Bought Deal Offering

Financings May 14, 2026 · 19:11

iFabric’s record quarter swiftly followed by upsized share dump and insider cash‑out.

Financings May 13, 2026 · 16:06

iFabric’s $20M bought deal at discount clouds record quarter, as founders sell near all‑time highs.

Financings May 12, 2026 · 06:30

iFabric’s Earnings Surge Defies Skeptics as Scrubs Scale Up, Margins Shine

Earnings